Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
|
In Today's Vidyya The number of Americans who will develop Alzheimer's disease is expected to increase by more than 250 percent by the year 2050. |
|
November Is National Alzheimer's Disease Month The number of Americans expected to develop Alzheimer's disease will increase by more than 250 percent by the year 2050. Currently, more than 4 million Americans suffer from the disease and that number is expected to grow to more than 14 million in 50 years due to the aging population in the United States. More... |
|
Postive Results For First Oral Therapy For Pulmonary Hypertension In Phase III Trial Patients receiving Tracleertm (bosentan), the first oral therapy for pulmonary hypertension (PHT), demonstrated significant improvements in their exercise ability and hemodynamics, according to results of a clinical trial presented today at the American Heart Association 73rd Annual Scientific Session. More... |
|
Clioquinol, An Existing Medication Is Being Tested On 36 Alzheimer's Patients
Prana Biotechnology Limited has announced that a potential treatment for Alzheimer's Disease was presented at the annual meeting of the Society for Neuroscience in New Orleans. The drug, Clioquinol was approved for human use decades ago. More... |
|
In People With Type 2 Diabetes, Xenical (Orlistat) May Help Reduce Heart Disease Risk People with type 2 diabetes who take the weight-reducing medication Xenical(R) (orlistat) may significantly reduce their long-term risk of coronary heart disease, according to a new study presented here today at the American Heart Association's annual scientific session. More... |
|
Information For Patients: Alzheimer's Disease This informational handout on Alzheimer's disease (AD) explains that AD is a progressive, neurodegenerative disease characterized by memory loss, language deterioration, impaired visuospatial skills, poor judgment, indifferent attitude, but preserved motor function. AD usually begins after age 65, however, its onset may occur as early as age 40, appearing first as memory decline and, over several years, destroying cognition, personality, and ability to function. The handout also lists resources where families can elicit help. More... |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.